"Beter voor Elkaar In het Ikazia Ziekenhuis willen we met respect vóór elkaar het beste úit elkaar halen. Van arts tot patiënt, van verpleegkundige tot familielid; iedereen is er voor iedereen. Door de mix van oprechte interesse, onderlinge verbondenheid en betrouwbaarheid voelen mensen zich thuis bij Ikazia. Wat ons betreft een belangrijke factor bij het herstel van een patiënt. Daarnaast is de medische kwaliteit in het Ikazia Ziekenhuis uitstekend op orde. Met elkaar werken we aan continue verbetering van de kwalitatief hoogwaardige zorg. We zijn een middelgroot ziekenhuis waarin u vrijwel alle specialismen vindt."

During the past decade, Ikazia Ziekenhuis conducted 41 clinical trials. In the 10-year time frame, 41 clinical trials started and 15 clinical trials were completed, i.e. on average, 36.6% percent of trials that started reached the finish line to date. In the past 5 years, 22 clinical trials started and 7 clinical trials were completed. i.e. 31.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ikazia Ziekenhuis" #1 sponsor was "Erasmus Medical Center" with 5 trials, followed by "Stichting Hemato-Oncologie voor Volwassenen Nederland" with 4 trials sponsored, "Pfizer" with 3 trials sponsored, "Population Health Research Institute" with 3 trials sponsored and "Radboud University Medical Center" with 3 trials sponsored. Other sponsors include 46 different institutions and companies that sponsored additional 45 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ikazia Ziekenhuis" #1 collaborator was "ZonMw: The Netherlands Organisation for Health Research and Development" with 4 trials as a collaborator, "Borstkanker Onderzoek Groep" with 3 trials as a collaborator, "Erasmus Medical Center" with 3 trials as a collaborator, "Canadian Institutes of Health Research (CIHR)" with 2 trials as a collaborator and "Cephalon" with 2 trials as a collaborator. Other collaborators include 69 different institutions and companies that were collaborators in the rest 74 trials.

According to Clinical.Site data, the most researched conditions in "Ikazia Ziekenhuis" are "Breast Cancer" (5 trials), "Atrial Fibrillation" (3 trials), "Colorectal Cancer" (3 trials), "Severe Sepsis" (3 trials) and "Ulcerative Colitis" (3 trials). Many other conditions were trialed in "Ikazia Ziekenhuis" in a lesser frequency.

Most popular intervention types in "Ikazia Ziekenhuis" are "Drug" (51 trials), "Other" (9 trials), "Procedure" (8 trials), "Biological" (5 trials) and "Device" (5 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (21 trials), "Golimumab" (2 trials), "Guselkumab" (2 trials), "JNJ-78934804" (2 trials) and "bococizumab (PF-04950615)" (2 trials). Other intervention names were less common.

The vast majority of trials in "Ikazia Ziekenhuis" are 62 trials for "All" genders, 6 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Ikazia Ziekenhuis". undefined are not yet recruiting, 14 are recruiting, 9 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 30 completed trials in Ikazia Ziekenhuis, 1 suspended trials, and 10 terminated clinical trials to date.

Out of the total trials that were conducted in Ikazia Ziekenhuis, 0 "Phase 1" clinical trials were conducted, 18 "Phase 2" clinical trials and 28 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 9 trials, and there were also 8 trials that are defined as “Not Applicable".

Ikazia Ziekenhuis has several departments that took part in Clinical trials: "Ikazia Ziekenhuis; Interne Oncologie" - 2 trials